Explore

Slice the corpus on any axis.

Filter by firm, year, function, metric or slide category — then see the result as a narrative arc, a treemap of slide types, or a catalog of slides.

clear
51,416 slides across 1229 decks match.
Cost Comparison
GoldmanSachs · 2023 · competitive_analysis
Cost Comparison
6.17% — Margin Loan Rate
FinTech vs Financial Services
GoldmanSachs · 2023 · competitive_analysis
FinTech vs Financial Services
67% — Pre-Tax Margin
Broad, Global Addressable Market
GoldmanSachs · 2023 · market_sizing
Broad, Global Addressable Market
$262 Trillion — Global Financial Assets
Diversified Client Base – by Client Type¹
GoldmanSachs · 2023 · segmentation
Diversified Client Base – by Client Type¹
$370 Billion — Client Equity
Diversified Client Base – by Geography¹
GoldmanSachs · 2023 · segmentation
Diversified Client Base – by Geography¹
2.4 Million — Client Base
Sustainable Investing
GoldmanSachs · 2023 · other
Sustainable Investing
IBKR GlobalTrader
GoldmanSachs · 2023 · other
IBKR GlobalTrader
Recent Enhancements and New Products
GoldmanSachs · 2023 · other
Recent Enhancements and New Products
Recent Enhancements and New Products
GoldmanSachs · 2023 · other
Recent Enhancements and New Products
APPENDIX
GoldmanSachs · 2023 · appendix
APPENDIX
Non-GAAP Reconciliation
GoldmanSachs · 2023 · appendix
Non-GAAP Reconciliation
$3,213 — Adjusted net revenues
Non-GAAP Reconciliation
GoldmanSachs · 2023 · appendix
Non-GAAP Reconciliation
$1,139 — Adjusted net revenues
Goldman Sachs Global Healthcare Conference
GoldmanSachs · 2025 · cover
Goldman Sachs Global Healthcare Conference
Legal Disclaimers
GoldmanSachs · 2025 · disclaimer
Legal Disclaimers
DURASERT E™
GoldmanSachs · 2025 · context
DURASERT E™
DURAVYU™: Vorolanib in bioerodible Durasert E™
GoldmanSachs · 2025 · other
DURAVYU™: Vorolanib in bioerodible Durasert E™
LUGANO/LUCIA Phase 3 Pivotal Trials in wet AMD
GoldmanSachs · 2025 · transition
LUGANO/LUCIA Phase 3 Pivotal Trials in wet AMD
Phase 2 VERONA Clinical Trial in DME
GoldmanSachs · 2025 · section_divider
Phase 2 VERONA Clinical Trial in DME
Phase 2 VERONA Clinical Trial in DME
GoldmanSachs · 2025 · section_divider
Phase 2 VERONA Clinical Trial in DME
VERONA: Phase 2 Clinical Trial Summary
GoldmanSachs · 2025 · key_takeaways
VERONA: Phase 2 Clinical Trial Summary
Goldman Sachs Global Healthcare Conference
GoldmanSachs · 2025 · cover
Goldman Sachs Global Healthcare Conference
2017 Euroscape
Accel · cover
2017 Euroscape
Market Update
Accel · agenda
Market Update
...at different stages of growth...
Accel · peer_benchmark
...at different stages of growth...
Market Update
Accel · section_divider
Market Update
The next generation
Accel · other
The next generation
1,000+ — SaaS company count
Accel Euroscape 2017
Accel · market_landscape
Accel Euroscape 2017
Euroscape 2017 demographics
Accel · market_landscape
Euroscape 2017 demographics
Market Update
Accel · section_divider
Market Update
"Crystal balling" 2018
Accel · industry_trends
"Crystal balling" 2018
Thank you !
Accel · closing_ask
Thank you !
Disclaimer
Accel · disclaimer
Disclaimer
RMB Morgan Stanley Off Piste
MorganStanley · 2019 · cover
RMB Morgan Stanley Off Piste
Market insight
MorganStanley · 2019 · section_divider
Market insight
Performance
MorganStanley · 2019 · section_divider
Performance
Business initiatives
MorganStanley · 2019 · section_divider
Business initiatives
Key tasks for H2 2019 and 2020
MorganStanley · 2019 · initiative_list
Key tasks for H2 2019 and 2020
Quilter's multi-channel advice-led model
MorganStanley · 2019 · other
Quilter's multi-channel advice-led model
Q&A
MorganStanley · 2019 · transition
Q&A
Disclaimer
MorganStanley · 2019 · disclaimer
Disclaimer
Quilter
MorganStanley · 2019 · other
Quilter
Table of contents
Deloitte · 2024 · table_of_contents
Table of contents
Foreword
Deloitte · 2024 · other
Foreword
Getting real about Generative AI
Deloitte · 2024 · executive_summary
Getting real about Generative AI
Getting real about Generative AI (cont'd)
Deloitte · 2024 · context
Getting real about Generative AI (cont'd)
46% — percentage of organizations
Getting real about Generative AI (cont'd)
Deloitte · 2024 · context
Getting real about Generative AI (cont'd)
Now: Key findings
Deloitte · 2024 · section_divider
Now: Key findings
Value creation
Deloitte · 2024 · key_takeaways
Value creation
Next page →